Regional Business Manager - Southwest at HeartFlow

Denver, Colorado, United States

Apply Now

$240,000 – $280,000Compensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, Medical Devices, CardiovascularIndustries

Requirements

Customer-facing experience with healthcare professionals including Cardiologists, Internists, general practitioners, Nurse practitioners, and physician assistants managing patients with ACS/CAD
Ability to hire, train, coach, and develop Territory Account Manager (TAM) teams to execute critical behaviors driving growth
Experience shaping sales organizations by creating cultures of performance and accountability
Capability to partner with TAMs and accounts to support, educate, and provide solutions for high customer satisfaction
Willingness to spend primary focus time with direct sales team and customers in the Southwest region

Responsibilities

Work cross-functionally to create solutions as new opportunities present
Create progressive programming that disrupts traditional means to reach ordering physicians treating and managing patients with CAD
Work directly with key strategic Heartflow accounts to drive growth and adoption of cCTA and FFRct clinical pathways, developing and executing business development plans with key stakeholders
Facilitate cross-functional collaboration with TSM, Marketing, Market Access, CT Apps, Product Development, and Clinical teams, deploying tools like internal leadership, physician mentors, dinner programs, VIP visits, CT Pathway road-shows, and referring physician office meetings
Increase Heartflow usage in designated key strategic accounts by maintaining and building relationships with referring physicians and key clinical stakeholders
Educate customers on Heartflow’s value proposition through presentations and discussions with referring MDs
Promote and champion Heartflow to build advocacy
Provide expectations, resources, and coaching to TAM team to drive Heartflow adoption through referring physician networks
Evaluate Territory Account Manager performance/success based on achievement of growth results

Skills

Sales Management

Team Leadership

Account Management

Business Development

Medical Device Sales

Customer Success

Training and Coaching

Performance Management

Territory Management

Cardiology Sales

HeartFlow

Non-invasive cardiac testing for heart disease

About HeartFlow

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company offers several analyses, including FFRCT Analysis and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries, including the United States, the United Kingdom, Japan, and Canada. Unlike many competitors, HeartFlow focuses on providing a comprehensive suite of analyses that enhance treatment planning. The goal of HeartFlow is to improve cardiovascular care by making it safer and more efficient for both patients and healthcare providers.

Redwood City, CaliforniaHeadquarters

2010Year Founded

$858.5MTotal Funding

SERIES_FCompany Stage

HealthcareIndustries

501-1,000Employees

Benefits

Remote Work Options

Stock Options

401(k) Company Match

Risks

Emerging AI-driven competitors could threaten HeartFlow's market share.

Algorithmic bias in AI models could lead to inaccurate diagnoses.

Integration into healthcare systems may face resistance due to complexity and cost.

Differentiation

HeartFlow offers the only combined anatomy, physiology, and plaque analysis for heart disease.

HeartFlow's non-invasive FFRCT Analysis is FDA-cleared and widely available globally.

HeartFlow's AI-driven technology provides personalized 3D heart models for precise diagnostics.

Upsides

HeartFlow closed a $215 million Series F funding round in April 2023.

The global non-invasive cardiac imaging market is projected to grow significantly.

HeartFlow's technology aligns with the trend towards value-based care in healthcare.

Land your dream remote job 3x faster with AI

Try Jobo Free